Shopping Cart
Remove All
Your shopping cart is currently empty
Belantamab mafodotin (Alias: GSK2857916, GSK 2857916, Belantamab mafodotin-blm)
Catalog No. T77903 Copy Product Info
🥰Excellent
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
Belantamab mafodotin
Copy Product Info🥰Excellent
Catalog No. T77903
Alias GSK2857916, GSK 2857916, Belantamab mafodotin-blm
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
Belantamab mafodotin
Cas No. 2050232-20-5
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $297 | In Stock | In Stock | |
| 5 mg | $778 | - | In Stock | |
| 10 mg | $1,230 | - | In Stock | |
| 25 mg | $1,830 | - | In Stock |
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:99.14% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma. |
| Targets&IC50 | BCMA (human):1 nM (Kd) |
| In vitro | Belantamab mafodotin is an immune conjugate (ADC) that targets B cell maturation antigens. The Kd value of Belantamab mafodotin binding human BCMA protein was 1 nM. Belantamab mafodotin induces G2/M phase arrest in multiple myeloma cells in a dose - and time-dependent manner. [1] |
| In vivo | Belantamab mafodotin significantly improved survival in mice with OPM2 tumors. [1] |
| Synonyms | GSK2857916, GSK 2857916, Belantamab mafodotin-blm |
| Reactivity | Human |
| Verified Activity | Immobilized Human BCMA Protein (ECD, His) at 2 μg/mL can bind Belantamab mafodotin. The EC50 is 0.02634 μg/mL  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | MMAF |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF17/BCMA/CD269 |
| Molecular Weight | 146.06 kDa |
| Cas No. | 2050232-20-5 |
| Isotype | IgG1 kappa-McMMAF |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Keywords
Preview
Related Tags: buy Belantamab mafodotin | purchase Belantamab mafodotin | Belantamab mafodotin cost | order Belantamab mafodotin | Belantamab mafodotin in vivo | Belantamab mafodotin in vitro | Belantamab mafodotin molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.